Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190210042676N16
IRCT20190210042676N16
Recruiting
Phase 2

Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo) in reducing diffuse and scattered hair loss and Improving hair volume and density

Akhavi laboratory0 sites19 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Akhavi laboratory
Enrollment
19
Status
Recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Male or female aged 18\-55 years
  • •Diffuse and scattered hair loss (Count at least 300 hairs in a combing test over three days)
  • •General health
  • •Voluntary participation and signing written informed consent

Exclusion Criteria

  • •Chronic active scalp disease other than hair loss
  • •Using any prescribed drug or OTC for hair loss within the past 3 months
  • •Any severe weight loss or strict diet therapy during the study
  • •Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of the safety and efficacy of the BioWeld1 system in the treatment of acne vulgarisACNE VULGARISL70.0Acne vulgaris
DRKS00025008IonMed Ltd.34
Not yet recruiting
Phase 1
Evaluation of the effectiveness and safety of bianshi moxibustion infrared dry eye therapeutic instrument in the treatment of meibomian gland dysfunctiomeibomian gland dysfunction
ITMCTR1900002769Peking University Third Hospital
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for Facial ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Facial Contouring
TCTR20230516008ASTRACO MEDICAL NETWORKS LTD.39
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for cheek and nasolabial fold ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Cheek and nasolabial fold Contouring
TCTR20230515001ASTRACO MEDICAL NETWORKS LTD.39
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital RejuvenatioHealthy PatientBipolar Radiofrequency-Assisted Lipolysis,Adjustable-depth fractional microneedle bipolar radiofrequency,periorbital Rejuvenation
TCTR20230417001ASTRACO MEDICAL NETWORKS LTD.38